IRIDEX Corporation's shares rallied over the past several weeks on news it was conducting a strategic review. On November 1, the stock cratered as the company disclosed possible concerns with Medicare ...
IRIDEX has faced delays in selling its assets as part of a strategic review initiated a year ago, causing frustration among shareholders. Despite setbacks, the company remains committed to selling all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback